Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Dupuytren Contracture × Collagenases × Clear all

Phase

Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Dupuytren Contracture 2 Rare Diseases 1 Connective Tissue Diseases 1 Arthritis 1

Interventions

Microbial Collagenase 6 xiapex 3 Collagenases 2 Triamcinolone Acetonide 1 Enzymes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02725528 2023-07-18

EXTEND

McMaster University

Phase 3 Completed

22 enrolled 15 charts

Dupuytren Contracture

NCT00014742 2015-03-25

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 3 Completed

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡